News

IDEAYA Biosciences Engages in Upcoming Investor Events

IDEAYA Biosciences Engages in Upcoming Investor Events

IDEAYA Biosciences Engages in Upcoming Investor Events

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is making strides in the field of precision medicine oncology. The company recently shared exciting updates regarding their involvement in notable investor relations events.

2025 RBCCM Ophthalmology Conference

One of the highlighted occasions is the 2025 RBCCM Ophthalmology Conference, scheduled for April 3, 2025, at 11:30 AM ET. During this event, attendees can look forward to an engaging fireside chat featuring Yujiro S. Hata, President and CEO, alongside Darrin Beaupre, Chief Medical Officer. This discussion will be facilitated by Gregory Renza, M.D., who serves as the Director and Senior Biotechnology Research Analyst.

Stifel 2025 Virtual Targeted Oncology Forum

Another significant event is the Stifel 2025 Virtual Targeted Oncology Forum, taking place on April 8, 2025, at 12:00 PM ET. This interactive session will also include a fireside chat with Yujiro S. Hata, President and CEO, hosted by Benjamin Burnett, Ph.D., Managing Director and Equity Analyst. These forums offer valuable insights into IDEAYA's innovative approaches and research progress.

Accessing Live Webcast

Interested parties can tune in to a live audio webcast of these events, if permitted by the respective conference hosts. The webcasts will be available on the "Investors/Events" section of the IDEAYA website, allowing participants to engage with the discussions and insights shared. Additionally, a replay of the webcast will be accessible for 30 days following the live events.

About IDEAYA Biosciences

IDEAYA Biosciences is passionately dedicated to revolutionizing the landscape of oncology through precision medicine. The company focuses on discovering and developing targeted therapeutics that align with molecular diagnostics for specific patient populations. By harnessing the power of translational biomarkers, IDEAYA aims to ensure that its innovative therapies reach the patients who stand to benefit the most.

Innovative Approach to Drug Discovery

Incorporating early research and drug discovery, IDEAYA is notably advancing its studies in synthetic lethality—a promising avenue in precision medicine. This strategy facilitates the identification of optimal therapeutic targets tailored to individual patient profiles, ultimately enhancing treatment efficacy.

Frequently Asked Questions

What is IDEAYA Biosciences known for?

IDEAYA Biosciences specializes in precision medicine oncology, focusing on developing targeted therapeutics based on molecular diagnostics.

When are the upcoming investor events?

The investor events include the 2025 RBCCM Ophthalmology Conference on April 3, 2025, and the Stifel 2025 Virtual Targeted Oncology Forum on April 8, 2025.

Who will be speaking at these conferences?

Yujiro S. Hata, President and CEO, will be speaking at both events, alongside Darrin Beaupre and Benjamin Burnett, Ph.D.

How can one access the live webcasts?

The live webcasts will be available on the IDEAYA website under the "Investors/Events" section for viewers to access during the events.

What is the vision of IDEAYA Biosciences?

IDEAYA is dedicated to transforming oncology with innovative therapies, ensuring the right drugs reach the right patients through personalized treatment approaches.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Heafner Takes Helm at HGTC Amid Strategic Shifts

Updated Category News Views 2

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

Continue Reading
AI Agents Challenge Product Governance Models

Updated Category News Views 6

AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...

Continue Reading
Crimson Coward's Cheez Nugs Shake Up Fast-Casual Scene

Updated Category News Views 7

New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...

Continue Reading
Chattanooga: A New Epicenter for Quantum Computing

Updated Category News Views 3

Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...

Continue Reading
Bellissima Bags Allure Award for Curly Hair Tool

Updated Category News Views 4

Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...

Continue Reading
DAHON's Tech: Crafting Folders That Ride Like Road Bikes

Updated Category News Views 4

The Folding Bike Revolution: More Than Just a Fad You've seen them zipping around—those compact, folding bikes. They're not just for urban commuters looking to save space. Oh no, this is a full-blown cycling revolution we're talking about. DAHON, a name that's been rolling since 1982, has been riding these waves and making strides that others can only dream of. While...

Continue Reading
FOSSI Opens 2027 Applications for Future STEM Leaders

Updated Category News Views 3

Paving Pathways in the Chemical Industry There's something brewing that's got me eyeing the future with cautious optimism, and it doesn't involve hedge funds or earnings reports. It's the Future of STEM Scholars Initiative (FOSSI) playing its cards just right, planting seeds for tomorrow's innovators. This puppy opened the gates for 2027 applications, and for young brains...

Continue Reading
AI Ambassadors Rethink Arbitration's Future

Updated Category News Views 5

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...

Continue Reading
Digital Wine Atlas Maps 4.3 Million Vineyards Globally

Updated Category News Views 4

Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...

Continue Reading
Arizona Voters Demand Clear Plans for 2026 Election

Updated Category News Views 3

A Shift in Voter Expectations: Clear Actions Needed Arizona voters have spoken, and they aren't looking for the same old political song and dance anymore. They crave something meatier—action, not just words. Heading into the 2026 general election, folks in the Grand Canyon State are demanding concrete solutions and straightforward answers from those who seek to lead...

Continue Reading
iv>

Top 5 Most Recently Viewed Articles

Northfield Capital Secures $2.1M Through Private Placement

Updated Category News Views 162

Northfield Capital Completes Successful Equity Offering Northfield Capital Corporation (TSX-V: NFD.A) has recently wrapped up a significant non-brokered private placement, successfully raising $2,146,000 through the issuance of 107,300 units. Each unit is priced at $20.00 and comprises one class A restricted voting share and a share purchase warrant. Investors will be...

Continue Reading
Transforming Mortgages: VantageScore 4.0 Reshapes Home Buying

Updated Category News Views 109

VantageScore 4.0 Implementation Marks a New Era in Mortgages The Federal Housing Finance Agency (FHFA) is making a bold move by allowing the use of VantageScore 4.0 for mortgages sold to significant players in the housing market. This pivotal decision brings much-needed competition to the credit scoring landscape, which has remained largely unchanged for decades. By...

Continue Reading
Exploring AYVAKIT's Promise for Systemic Mastocytosis Patients

Updated Category News Views 218

Blueprint Medicines Highlights AYVAKIT Efficacy for Systemic Mastocytosis Blueprint Medicines Corporation has recently unveiled data demonstrating the sustained clinical efficacy and safety profile of AYVAKIT (avapritinib) for the treatment of systemic mastocytosis (SM). The company continues to underscoring its commitment to improving patient care through a series of...

Continue Reading
Josh Allen Rookie Card Sells for Record $1.7M

Updated Category News Views 6

Million-Dollar Card: A Trophy for Investors Think back to a time when shelling out a few bucks for trading cards was child's play. Fast forward to today, and we have a Josh Allen 1/1 rookie card going under the hammer for a jaw-dropping $1.7 million. Yeah, that's right—a sports card rivaling pieces of modern art in valuation. Who'd have guessed it? This figure not only...

Continue Reading
Lessons from a Failed Launch: Why Solana Developers Can't Ignore Infrastructure Planning

Updated Category Crypto Views 57

The launch was supposed to be perfect. Jasmine and her team had spent six months building a Solana-based NFT marketplace. She'd even set a launch date and invited 1,000 early access users. Then launch day arrived, and within the first hour, her marketplace crashed. As she picked through the wreckage of her launch, she realized the fatal mistake: she'd built an incredible...

Continue Reading